Summary
The product 3-TRENBOMED 150, manufactured by DEUS Medical and submitted by DEUSPOWER.SHOP, underwent qualitative and quantitative analysis of AAS oil. The analysis conducted by Janoshik Analytical revealed the presence of three trenbolone compounds: acetate, hexahydrobenzylcarbonate, and enanthate.
The sample was ordered for testing on 5 January 2021, received on 6 January 2021, and analyzed the same day.
Detailed Report
Product Overview
- Manufacturer: DEUS Medical
- Product Name: 3-TRENBOMED 150
- Active Ingredients: Trenbolone Acetate, Trenbolone Hexahydrobenzylcarbonate, Trenbolone Enanthate
- Batch Number: QJ67647; Mfg. 11/2020
- Expiration Date: Not provided
- Delivery Method: Injectable AAS oil
Sample Acquisition and Testing
- Task Number: #09569
- Testing Ordered: 5 January 2021
- Sample Received: 6 January 2021
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.SHOP
- Analysis Paid For By: DEUSPOWER.SHOP
Testing Results
| Compound | Measured Concentration (mg/ml) |
|---|---|
| Trenbolone Acetate | 48.51 mg/ml |
| Trenbolone Hexahydrobenzylcarbonate | 50.16 mg/ml |
| Trenbolone Enanthate | 49.62 mg/ml |
Verification Details
- Verification URL: https://janoshik.com/tests/09569_4W9BIWIYS2MT
Evaluation of Reseller-Submitted Testing
The sample shows relatively balanced concentrations across all three trenbolone compounds, which is consistent with the intended formulation of 150 mg/ml total. However, each compound individually falls slightly below expected concentration levels.
Conclusion
The tested batch of 3-TRENBOMED 150 contains trenbolone compounds in reasonable amounts but with slight variations from the ideal target concentrations.
Disclaimer
This report is intended for educational and harm-reduction purposes. Reseller-submitted testing can provide valuable insights but may reflect selective sampling. Consumers are encouraged to make informed decisions and consider further independent analysis.
